hydralazine and aspirin

hydralazine has been researched along with aspirin in 20 studies

Research

Studies (20)

TimeframeStudies, this research(%)All Research%
pre-19906 (30.00)18.7374
1990's4 (20.00)18.2507
2000's6 (30.00)29.6817
2010's4 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aldana, I; Alvarez, T; Bermejillo, MJ; Fernandez-Alvarez, E; Font, M; Latre, JA; Lopez-Unzu, MJ; Monge, A; Santiago, E1
Topliss, JG; Yoshida, F1
Lombardo, F; Obach, RS; Waters, NJ1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ahnfelt-Rønne, I; Arrigoni-Martelli, E1
Bartels, T; Beitz, J; Heinemann, S; Hoffmann, P; Taube, C1
Garcia-Marquez, F; Vidrio, H1
Lendvay, LJ; Paolini, JP1
Graeme, ML; John, M; Sigg, EB1
Bambach, D; Fontana, ME; Hermiller, JB; Huss, P; Leier, CV; Magorien, RD; Thompson, MJ; Unverferth, DV1
Kawashima, A; Koike, H; Nishio, S; Ueno, Y1
Giles, TD1
Agostoni, P; Alimento, M; Contini, M; Guazzi, M; Marenzi, G1
Bednar, MM; Ellenberger, C; Gross, CE; Howard, DB; Russell, SR1
Leavitt, K; Običan, S; Yankowitz, J1

Reviews

3 review(s) available for hydralazine and aspirin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Optimizing the treatment of heart failure.
    Current opinion in cardiology, 1994, Volume: 9 Suppl 1

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium Channel Blockers; Captopril; Clinical Trials as Topic; Contraindications; Digitalis; Digoxin; Diuretics; Enalapril; Heart Failure; Humans; Hydralazine; Lisinopril; Nitrates; Plants, Medicinal; Plants, Toxic; Randomized Controlled Trials as Topic; Stroke Volume

1994
Treatment and Prevention of Hypertensive Disorders During Pregnancy.
    Clinics in perinatology, 2019, Volume: 46, Issue:2

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Chronic Disease; Clonidine; Cyclooxygenase Inhibitors; Diuretics; Female; Humans; Hydralazine; Hypertension; Hypertension, Pregnancy-Induced; Maternal-Fetal Exchange; Pre-Eclampsia; Pregnancy; Pregnancy Complications

2019

Trials

1 trial(s) available for hydralazine and aspirin

ArticleYear
Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin.
    Circulation, 1997, Apr-01, Volume: 95, Issue:7

    Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood-Air Barrier; Bradykinin; Cyclooxygenase Inhibitors; Diffusion; Double-Blind Method; Enalapril; Epoprostenol; Exercise Test; Female; Heart Failure; Humans; Hydralazine; Hypertension; Isosorbide Dinitrate; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Alveoli; Pulmonary Circulation; Pulmonary Gas Exchange; Respiratory Function Tests

1997

Other Studies

16 other study(ies) available for hydralazine and aspirin

ArticleYear
New 5H-pyridazino[4,5-b]indole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation and inotropics.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:10

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiotonic Agents; Dinoprostone; Female; Guinea Pigs; Humans; Indoles; Platelet Aggregation Inhibitors; Pyridazines; Thromboxane A2; Thromboxane-A Synthase

1991
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Rabbit lung microsomes: a rapid method for assaying simultaneously drug effects on thromboxane and prostacyclin synthesis.
    Agents and actions. Supplements, 1979, Issue:4

    Topics: Animals; Arachidonic Acids; Aspirin; Burimamide; Dipyridamole; Epoprostenol; Hydralazine; Imidazoles; Indomethacin; Lung; Microsomes; Prostaglandins; Rabbits; Thromboxanes

1979
Cardiovascular actions of dihydralazine as modified by dietary linoleic acid.
    Biomedica biochimica acta, 1986, Volume: 45, Issue:8

    Topics: Animals; Aorta, Abdominal; Aspirin; Blood Pressure; Dietary Fats; Dihydralazine; Epoprostenol; Fatty Acids; Female; Hydralazine; In Vitro Techniques; Indomethacin; Kidney; Linoleic Acid; Linoleic Acids; Male; Phospholipids; Pregnancy; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Species Specificity

1986
The influence of cyclo-oxygenase inhibitors on the cardiovascular effects of hydralazine in rats.
    Archives internationales de pharmacodynamie et de therapie, 1985, Volume: 273, Issue:1

    Topics: Animals; Aspirin; Blood Pressure; Body Temperature; Cyclooxygenase Inhibitors; Heart Rate; Hemodynamics; Hydralazine; Indomethacin; Male; Prostaglandins; Rats; Rats, Inbred Strains; Vasodilation

1985
Heterocyclic systems with a bridgehead nitrogen. II. 6-Chloroimidazo[2,1-b]thiazole and some of its 5-substituted derivatives.
    Journal of medicinal chemistry, 1969, Volume: 12, Issue:6

    Topics: Animals; Aspirin; Blood Pressure; Chemical Phenomena; Chemistry; Enterobacteriaceae; Female; Fungi; Hydralazine; Hypertension; Inflammation; Magnetic Resonance Spectroscopy; Male; Mice; Phenylbutazone; Rats; Thiazoles

1969
Induction of periarthritis by oral administration of 6-sulfanilamidoindazole and its treatment in rats.
    The Journal of pharmacology and experimental therapeutics, 1967, Volume: 157, Issue:1

    Topics: Animals; Aspirin; Chloroquine; Cloxacillin; Hydralazine; Hydrocortisone; Indomethacin; Male; Mercaptopurine; Methotrexate; Morphine; ortho-Aminobenzoates; Oxyphenbutazone; Paramethasone; Periarthritis; Phenylbutazone; Rats; Sulfinpyrazone; Sulfonamides

1967
Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Annals of internal medicine, 1982, Volume: 97, Issue:4

    Topics: Adolescent; Adult; Aspirin; Diazoxide; Dipyridamole; Female; Hemodynamics; Humans; Hydralazine; Hypertension, Pulmonary; Indomethacin; Isoproterenol; Isosorbide Dinitrate; Middle Aged; Phentolamine; Prostaglandin Antagonists; Tolazoline; Vascular Resistance; Vasodilator Agents

1982
Effect of beraprost sodium, a stable prostacyclin analogue, on pulmonary thromboembolism in mice.
    Thrombosis research, 1995, Jan-15, Volume: 77, Issue:2

    Topics: Administration, Oral; Alprostadil; Animals; Aspirin; Bridged Bicyclo Compounds; Collagen; Diltiazem; Drug Evaluation, Preclinical; Epinephrine; Epoprostenol; Fatty Acids, Monounsaturated; Fibrinolytic Agents; Heparin; Hydralazine; Injections, Intravenous; Isosorbide Dinitrate; Male; Mice; Nifedipine; Nitroprusside; Platelet Aggregation Inhibitors; Pulmonary Embolism; Superoxide Dismutase; Vasodilator Agents

1995
The effect of vasodilators on aspirin-induced antagonism of t-PA thrombolysis.
    Neurological research, 2001, Volume: 23, Issue:7

    Topics: Animals; Antihypertensive Agents; Aspirin; Atenolol; Brain Ischemia; Cerebrovascular Circulation; Drug Interactions; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hydralazine; Male; Nitric Oxide; Nitric Oxide Donors; Prostaglandins, Synthetic; Rabbits; Thromboembolism; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Vasodilator Agents

2001